William R. Sellers

Alıntı yapanlar

	Hepsi	2019 yılından bugüne
Alıntılar	96603	30227
h-endeksi	126	75
i10-endeksi	214	186

7000

3500

1750

5250

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024271 332 396 385 510 546 627 639 1040 2227 2766 3035 3306 3442 3855 4256 4797 5378 5505 5580 5547 5477 5139 5478 5685 6415 5796 5142 1694

Genel erişim

Tümünü görüntüle

61 makale

3 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Levi GarrawayAssociate Professor of Medicine, Harvard Medical Schooldfci.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Rameen BeroukhimDana-Farber Cancer Institute, Harvard Medical Schoolbroadinstitute.org üzerinde doğrulanmış e-posta adresine sahip
Todd GolubBroad Institutebroadinstitute.org üzerinde doğrulanmış e-posta adresine sahip
Mark A RubinProfessor & Director Department for BioMedical Research, University of Berndbmr.unibe.ch üzerinde doğrulanmış e-posta adresine sahip
Phil Febbo, M.D.Illumina, incillumina.com üzerinde doğrulanmış e-posta adresine sahip
Stacey GabrielThe Broad Institute of Harvard and MITbroadinstitute.org üzerinde doğrulanmış e-posta adresine sahip
Cheng LiPrincipal Investigator, School of Life Sciences, Peking University, Beijing, Chinapku.edu.cn üzerinde doğrulanmış e-posta adresine sahip
Sabina SignorettiProfessor, Brigham and Women's Hospital, Harvard Medical Schoolbwh.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Joshua M KornNovartis Institutes for Biomedical Researchalum.mit.edu üzerinde doğrulanmış e-posta adresine sahip
Frederic KayeUniversity of Floridaufl.edu üzerinde doğrulanmış e-posta adresine sahip
Christopher John WilsonStylus, Editas, Novartis, MIT, Arqule, Akcelialum.mit.edu üzerinde doğrulanmış e-posta adresine sahip
Titus BoggonYale University School of Medicineyale.edu üzerinde doğrulanmış e-posta adresine sahip
Gad GetzMassachusetts General Hospital and Broad Institute of Harvard and MITbroadinstitute.org üzerinde doğrulanmış e-posta adresine sahip
Pascal FuretDirector and leading scientist at Novartisnovartis.com üzerinde doğrulanmış e-posta adresine sahip
Kenneth N RossDana-Farber Cancer Instituteieee.org üzerinde doğrulanmış e-posta adresine sahip
Alan HuangTango Therapeuticstangotx.com üzerinde doğrulanmış e-posta adresine sahip
John MinnaProfessor of Internal Medicine and Pharmacology, University of Texas Southwestern Medical Centerutsouthwestern.edu üzerinde doğrulanmış e-posta adresine sahip
Neal RosenProfessor of Pharmacology, Memorial Sloan-Kettering Cancer Centermskcc.org üzerinde doğrulanmış e-posta adresine sahip
PABLO TAMAYOProfessor, Division of Genomics and Precision Medicine, UC San Diegoucsd.edu üzerinde doğrulanmış e-posta adresine sahip
Erik FlemingtonProfessor of Tulane Universitytulane.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

William R. Sellers

Core Institute Member, The Broad Institute

broadinstitute.org üzerinde doğrulanmış e-posta adresine sahip

Cancer Therapeutics and Genetics


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy JG Paez, PA Janne, JC Lee, S Tracy, H Greulich, S Gabriel, P Herman, ... Science 304 (5676), 1497-1500, 2004	11938	2004
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ... Nature 483 (7391), 603-607, 2012	7711	2012
The landscape of somatic copy-number alteration across human cancers R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ... Nature 463 (7283), 899-905, 2010	4190	2010
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis RL Levine, M Wadleigh, J Cools, BL Ebert, G Wernig, BJP Huntly, ... Cancer cell 7 (4), 387-397, 2005	3818	2005
Gene expression correlates of clinical prostate cancer behavior D Singh, PG Febbo, K Ross, DG Jackson, J Manola, C Ladd, P Tamayo, ... Cancer cell 1 (2), 203-209, 2002	3117	2002
Next-generation characterization of the cancer cell line encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503-508, 2019	2370	2019
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma LA Garraway, HR Widlund, MA Rubin, G Getz, AJ Berger, S Ramaswamy, ... Nature 436 (7047), 117-122, 2005	1783	2005
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors IK Mellinghoff, MY Wang, I Vivanco, DA Haas-Kogan, S Zhu, EQ Dia, ... New England Journal of Medicine 353 (19), 2012-2024, 2005	1719	2005
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation CM Johannessen, JS Boehm, SY Kim, SR Thomas, L Wardwell, ... Nature 468 (7326), 968-972, 2010	1713	2010
Molecular characterization of the tumor microenvironment in breast cancer M Allinen, R Beroukhim, L Cai, C Brennan, J Lahti-Domenici, H Huang, ... Cancer cell 6 (1), 17-32, 2004	1572	2004
BRAF mutation predicts sensitivity to MEK inhibition DB Solit, LA Garraway, CA Pratilas, A Sawai, G Getz, A Basso, Q Ye, ... Nature 439 (7074), 358-362, 2006	1536	2006
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo … SM Maira, F Stauffer, J Brueggen, P Furet, C Schnell, C Fritsch, ... Molecular cancer therapeutics 7 (7), 1851-1863, 2008	1349	2008
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response H Gao, JM Korn, S Ferretti, JE Monahan, Y Wang, M Singh, C Zhang, ... Nature medicine 21 (11), 1318-1325, 2015	1307	2015
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway I Sansal, WR Sellers Journal of clinical oncology 22 (14), 2954-2963, 2004	1245	2004
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma R Beroukhim, G Getz, L Nghiemphu, J Barretina, T Hsueh, D Linhart, ... Proceedings of the National Academy of Sciences 104 (50), 20007-20012, 2007	1235	2007
High-throughput oncogene mutation profiling in human cancer RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ... Nature genetics 39 (3), 347-351, 2007	1160	2007
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways PK Majumder, PG Febbo, R Bikoff, R Berger, Q Xue, LM McMahon, ... Nature medicine 10 (6), 594-601, 2004	1138	2004
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties WG Kaelin Jr, W Krek, WR Sellers, JA DeCaprio, F Ajchenbaum, ... Cell 70 (2), 351-364, 1992	1060	1992
Phosphorylation of the PTEN tail regulates protein stability and function F Vazquez, S Ramaswamy, N Nakamura, WR Sellers Molecular and cellular biology 20 (14), 5010-5018, 2000	946	2000
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage ME McMenamin, P Soung, S Perera, I Kaplan, M Loda, WR Sellers Cancer research 59 (17), 4291-4296, 1999	920	1999

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar